Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(25%)
Results Posted
25%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_4
1
13%
Ph phase_2
1
13%
Ph not_applicable
4
50%
Ph phase_3
2
25%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Active, not recruiting1
Recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (12.5%)
Phase 32 (25.0%)
Phase 41 (12.5%)
N/A4 (50.0%)

Trials by Status

active_not_recruiting113%
completed450%
recruiting113%
terminated113%
unknown113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
8